ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.93 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,825,090 | -64.7% | 492,924 | -74.1% | 0.20% | -55.2% |
Q1 2023 | $10,845,065 | -3.2% | 1,902,643 | 0.0% | 0.46% | -2.8% |
Q4 2022 | $11,206,567 | +84.1% | 1,902,643 | 0.0% | 0.47% | +86.2% |
Q3 2022 | $6,088,000 | +7.6% | 1,902,643 | +50.7% | 0.25% | +17.7% |
Q2 2022 | $5,656,000 | +140.4% | 1,262,464 | +186.5% | 0.22% | +198.6% |
Q1 2022 | $2,353,000 | -63.7% | 440,696 | 0.0% | 0.07% | -42.4% |
Q4 2021 | $6,478,000 | +107.8% | 440,696 | +195.6% | 0.12% | +135.8% |
Q3 2021 | $3,118,000 | -63.6% | 149,100 | -41.0% | 0.05% | -56.6% |
Q4 2020 | $8,561,000 | +232.1% | 252,910 | +230.9% | 0.12% | +121.8% |
Q2 2020 | $2,578,000 | – | 76,432 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 602,272 | $4,673,631 | 14.75% |
Nextech Invest Ltd. | 4,285,714 | $33,257,141 | 11.30% |
Column Group LLC | 3,568,181 | $27,689,085 | 10.75% |
Prosight Management, LP | 5,522,936 | $42,857,984 | 6.42% |
Invus Financial Advisors, LLC | 1,007,575 | $7,818,782 | 4.18% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,450,822 | $11,258,379 | 3.48% |
VR Adviser, LLC | 2,142,856 | $16,628,563 | 2.66% |
Euclidean Capital LLC | 747,550 | $5,800,988 | 1.49% |
Frazier Life Sciences Management, L.P. | 2,142,855 | $16,628,555 | 0.99% |
Monaco Asset Management SAM | 378,222 | $2,935,003 | 0.82% |